ACR Convergence 2025| Video: Rheuminations on Milestones & Ageism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: communication

The AMA Seeks Physician Input to Inform Medicare Physician Payment

From the College  |  October 9, 2023

The AMA’s Physician Practice Information Survey is seeking updated data on practice costs to inform Medicare physician payment.  If your practice receives a request to participate, complete this important survey to help ensure accurate payment.

Filed under:Uncategorized

Cannabis for Pain Relief: An Area Ripe for Research

Vanessa Caceres  |  September 28, 2023

Medical cannabis may benefit patients experiencing pain, and rheumatologists should be able to discuss its potential risks and benefits with their patients. Here are insights from Dr. Mary Ann Fitzcharles on current research, patient use and more.

Filed under:AnalgesicsConditionsDrug UpdatesPain Syndromes Tagged with:marijuanaPain Syndrome FocusRheum

Findings from a Clinical Trial of Dazodalibep for Sjögren’s Disease

Michele B. Kaufman, PharmD, BCGP  |  September 26, 2023

St.Clair et al. found that patients with Sjögren’s disease treated with dazodalibep experienced greater improvement in key symptoms of dryness, fatigue and pain than patients who received placebo.

Filed under:Biologics/DMARDsDrug UpdatesEULAR/OtherMeeting ReportsSjögren’s Disease Tagged with:EULAR 2023

The ACR Launches Rheumatoid Arthritis Measures Toolkit

Allison Plitman, MPA  |  September 25, 2023

The new resource offers standardized outcome measures for providers who treat patients with RA, as well as training materials for medical staff to guide accurate and efficient data collection. It also includes video tutorials and sample workflows for different EHR systems.

Filed under:ConditionsPractice SupportQuality Assurance/ImprovementRheumatoid Arthritis Tagged with:Rheumatoid Arthritis (RA)Rheumatology Informatics System for Effectiveness (RISE) clinical data registry

Break Barriers: Engaging Diverse Participants in Clinical Trials for Patients with Lupus

Jason Liebowitz, MD, FACR  |  September 14, 2023

Misinformation, fear and not having a trusted partner in the medical sector are just a few of the barriers that prevent patients of color from being adequately represented in research and clinical trials for lupus. Experts and patient advocates addressed how to remove these barriers and more during the 2023 ACR Diversification of Clinical Trials Summit.

Filed under:ConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:clinical trialsDiversitypatient education

Marching to the Biosimilar Beat: Questions on Rollout Remain

Ruth Jessen Hickman, MD  |  September 7, 2023

The availability of biosimilars for the treatment of patients with rheumatic diseases exploded in 2023. Here’s where we stand and what to expect going forward.

Filed under:Drug UpdatesHome Slider Tagged with:adalimumabBiosimilarsRA Resource Center

The Importance of Health Literacy in Clinical Care

Jason Liebowitz, MD, FACR  |  August 14, 2023

EULAR 2023—It is not enough to practice medicine by the book; rather, communication with patients and understanding their goals for patients are vital to high-quality care. At EULAR 2023, the session titled The Promise of Health Literacy in Clinical Care provided a treasure trove of insights for many clinicians. Definitions & Actions The first speaker…

Filed under:Meeting ReportsPatient PerspectivePractice Support Tagged with:EULAREULAR 2023health literacytelehealthtelemedicine

Benefits & Challenges of, & Potential Solutions for, Hybrid Conferences

Jamie E. Collins, PhD, Richard Conway, MB, BCH, BAO, PhD, Mrinalini Dey, MB, BChir, MA, MRCP, Laura B. Lewandowski, MD, MS, Jean W. Liew, MD, MS, Kaleb Michaud, PhD, Noelle A. Rolle, MBBS, Didem Saygin, MD, Grant S. Schulert, MD, PhD, Julia F. Simard, ScD, Beth I. Wallace, MD, MSc, & Kristen J. Young, DO, MEd  |  August 13, 2023

Early in the COVID-19 pandemic, scientific and medical conferences began to be canceled or postponed. Later, once the pandemic endured beyond the scope of weeks to months, many organizations shifted conferences to a virtual format. Now, as the federal government has ended the COVID-19 Public Health Emergency, effective mitigation measures, including vaccination, rapid testing, masking…

Filed under:Career DevelopmentEducation & TrainingProfessional Topics Tagged with:DiversityEquityinclusionOpinion

Rheuminations: Why I Don’t Use the Term ‘Stakeholder’

Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS  |  August 13, 2023

Modern healthcare is, for better or for worse, the hybrid of many different fields—some that are expected, such as biomedical science, and others that are less well appreciated, such as astrology and palmistry. One modern contributor to healthcare is management. Nowadays, we’re inundated with all sorts of jargon from the business and policy worlds: turnover,…

Filed under:OpinionProfessional TopicsRheuminations Tagged with:DiversityEquityinclusion

The Rheumatologist Honored with 2 Awards of Excellence

Keri Losavio  |  July 26, 2023

We are honored to announce that The Rheumatologist has received two Awards of Excellence from APEX 2023 for content published in calendar year 2022: an Award of Excellence in the category of Public Health Concerns—Health & Medical for the editorial supplement to the April issue, COVID-19: What We Know, and an Award of Excellence for…

Filed under:AwardsProfessional Topics Tagged with:COVID-19

  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 96
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences